Gelareh Farshid

Pathologist at Royal Adelaide Hospital | Professor @UniofAdelaide | Interested in breast & soft tissue pathology, breast cancer screening & digital pathology

[Gelareh Farshid @drgfarshid]

@ProfRAScolyer Congratulations Richard and team. Wishing you well, you are in my mind often

[Gelareh Farshid @drgfarshid]

@TheUSCAP We owe you a huge debt of gratitude Chris. Rest in peace

[Gelareh Farshid @drgfarshid]

@davidrbherlihy What the (medical) world needs now! So good!

[Gelareh Farshid @drgfarshid]

Great session at the ISBpath in Baltimore

[Gelareh Farshid @drgfarshid]

@ProfRScolyerMIA @MelanomaAus @ProfGLongMIA @AlboMP @ausoftheyear @PatrickGormanMP @Sydney_Uni @CPC_usyd @Dr_Brindha @AAHMS_health @SHPartners @PathologyRCPA Congratulations Richard and Georgina. Thank you for your services to numerous patients and colleagues. Richard: you and Katie are dear to your pathology family. All power to you.

[Oren Gottfried, MD @OGdukeneurosurg]

Intubated ICU patients using VR to take a short immersive vacation while getting some physical exercise in. Source: darlan nitz

[Gelareh Farshid @drgfarshid]

@ProfRScolyerMIA @ACurrentAffair9 @syd_health @CPC_usyd @SydneyLHD Go well Richard

[Erik A. Williams, MD @ErikAWilliamsM1]

We have uncovered a new molecular mechanism responsible for nearly one-third of sporadic schwannomas – recurrent insertion/deletion mutations in 𝑆𝑂𝑋10. https://t.co/H8SGsoOJTr

[Pathology Journal @Pathology_RCPA]

We're pleased to announce our Impact Factor for @Pathology_RCPA is 4.5, with a ranking of 18/76 among the world’s #pathology journals. Thank you and kudos to our authors, peer reviewers, editorial board and Editor-in-Chief @ProfRScolyerMIA.
Source: Clarivate 2023 #JCR2023

[Professor Richard Scolyer AO @ProfRAScolyer]

Hi all! Feeling great in neuro ICU at #RPAH/@SydneyLHD. Thanks so much to my friend & colleague Dr Brindha Shivalingam & team for meeting with my wife Dr Katie Nicoll & @ProfGLongMIA yesterday & for operating on me today! Thanks to friends & colleagues around world & @MelanomaAus

[Gelareh Farshid @drgfarshid]

@ProfRScolyerMIA @SydneyLHD @ProfGLongMIA @MelanomaAus @Sydney_Uni @NSWHPathology @CPC_usyd Wishing you and Katie all the best for today's surgery Richard. Generous of you to share your progress with all of us who care for you and admire you and Katie.

[Catriona Mckenzie @CatrionaMckenz5]

https://t.co/1Na4gNm9i4
It can be done “Progress is not linear. Gender equality does not happen unless we measure it and report on it, and ensure we guard against conscious and unconscious bias. @SaraEWobker @LJTafeMD @GuptaRuta @FionaMacPath @dahlstrom_jane @priyanthi_k2017

[Catriona Mckenzie @CatrionaMckenz5]

Thankyou AProf Cooper for presenting our poster at the @IAP_AUS showing underrepresentation of women in leadership positions, academia and awards. It is great to stimulate discussions about this @FionaMacPath @CArnold_Coach @Sara_Jiang @GuptaRuta @SaraEWobker @Vik_deshpandeMD

[Scott Kilpatrick, MD @ScottBikeethan]

Who dares answer these questions?
Deep soft tissue tumor of the foot in a 50+ male. Low power: partly nested to fascicular with transecting fibrous bands. High power, the cells are uniform, ovoid with pale to clear cytoplasm and prominent nucleoli.

[Gelareh Farshid @drgfarshid]

@mhassanaimc @LizaMQuintana @DrGeeONE @ADamronMD @fouad_boulos @Cristina_VargAP @QassidO @kis_lorand @MirunaPopescu13 @slusagar Probably is but would not call it outright. No calcs, no necrosis, no mitosis, 2 highly suspicious cells. If it turns out to be apocrine change, would be hard to justify a definitive dx of malignancy. Needs to have the area excised anyway

[Gelareh Farshid @drgfarshid]

@fouad_boulos @wusm_pathology @washupathedu Great pics, thank you. Papillary DCIS. The larger duct shows preservation of ME cells at the interface with the stroma

[Gelareh Farshid @drgfarshid]

@KemiMDRad @rovingatuscap @01sth02 I hope Foodbank Australia Counts too

[Gelareh Farshid @drgfarshid]

@AnneMillsMD @StanfordPath So good to see a photo of Dr Kempson. Thank you.

[Gelareh Farshid @drgfarshid]

@TristanRutland7 @ZHouseh @MattieFarzin @JMGardnerMD @Cristina_VargAP @HENRYY_MD @FionaMacPath @redsnapperpath @pepeheffernan @DrBMcGinn @Dr_Brian_Cox Thank you Tristan, don't see this often any more. Great example.

[ISBP @TheISBP]

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial https://t.co/ZvxfWOc6oI